| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 04/09/2002 | US6368821 Process for infecting eukaryotic cells with a bacterial virus |
| 04/09/2002 | US6368811 Syndecan interacting proteins and the use thereof |
| 04/09/2002 | US6368796 Methods of detection and treatment of breast cancer |
| 04/09/2002 | US6368790 cDNA encoding P2P proteins and use of P2P cDNA derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans |
| 04/09/2002 | US6368789 Screening methods to identify inhibitors of telomerase activity |
| 04/09/2002 | US6368601 Isolated dna |
| 04/09/2002 | CA1341356C Transkaryotic implantation |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002027006A1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
| 04/04/2002 | WO2002026984A2 Potassium channel interactors and uses therefor |
| 04/04/2002 | WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 04/04/2002 | WO2002026974A1 A novel polypeptide- transcription factor xap-2 protein 49.72 and the polynucleotide encoding said polypeptide |
| 04/04/2002 | WO2002026973A1 A novel polypeptide-human heterogeneous nuclear ribonucleoprotein 32.01 and the polynucleotide encoding said polypeptide |
| 04/04/2002 | WO2002026965A1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like |
| 04/04/2002 | WO2002026957A2 Regulation of a human serine protease |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026941A2 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | WO2002026936A2 Gene expression in the central nervous system regulated by neuroleptic agents |
| 04/04/2002 | WO2002026827A1 Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules |
| 04/04/2002 | WO2002026824A2 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues |
| 04/04/2002 | WO2002026820A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 04/04/2002 | WO2002026812A1 A novel peptide---human dna cgg repeated associative protein 16.17 and the polynucleotide coding this novel peptide |
| 04/04/2002 | WO2002026809A1 A new polypeptide- transmembrane 35.31 containing epidermal growth factor-like repeating domain and the polynucleotide encoding it |
| 04/04/2002 | WO2002026806A1 A novel peptide-human myosin heavy chain b22.22 and the polynucleotide coding this novel peptide |
| 04/04/2002 | WO2002026794A1 A novel polypeptide, a human ribosomal protein l7a20.57 and the polynucleotide encoding the polypeptide |
| 04/04/2002 | WO2002026765A2 Haplotypes of the muc1 gene |
| 04/04/2002 | WO2002026758A1 Oligonucleotide modulation of her-1 expression |
| 04/04/2002 | WO2002026251A1 Attenuated salmonella microorganisms comprising a mutation in the sifa gene |
| 04/04/2002 | WO2002026250A2 Vaccines for proliferative ileitis |
| 04/04/2002 | WO2002026246A2 Pharmaceutical compositions comprising polynucleotides encoding a raf protein |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002026192A2 Viruses targeted to hypoxic cells and tissues |
| 04/04/2002 | WO2002008435A8 Codon-optimized papilloma virus sequences |
| 04/04/2002 | WO2002004636A8 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 04/04/2002 | WO2002003961B1 Microspheres and adjuvants for dna vaccine delivery |
| 04/04/2002 | WO2001098487A8 Polynucleotides and polypeptides linked to blood pressure regulation and/or fatigue |
| 04/04/2002 | WO2001096587A8 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 04/04/2002 | WO2001094610A3 Binary hybrid mutational vectors |
| 04/04/2002 | WO2001090306A3 Compositions and methods for modulating tumor specific expression |
| 04/04/2002 | WO2001088106A3 Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 04/04/2002 | WO2001087376A8 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/04/2002 | WO2001087263A3 Delivery systems for treatment of vascular disease |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085784A3 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 04/04/2002 | WO2001080882A3 Methods and compositions for eliciting an immune response |
| 04/04/2002 | WO2001077294A3 Hpv-specific short-mers |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | WO2001072781A3 Human genes and expression products |
| 04/04/2002 | WO2001071017A3 Modified nodavirus rna for gene delivery |
| 04/04/2002 | WO2001068837A3 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 04/04/2002 | WO2001066566A3 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 04/04/2002 | WO2001062792A3 Cancer treatment and prognosis involving hes-1 protein |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001060350A3 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 04/04/2002 | WO2001058494A3 Gene therapy for treating ocular-related disorders |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2001048231A3 Method of achieving persistent transgene expression |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000070099A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 04/04/2002 | US20020040203 Method for transdermal or intradermal delivery of molecules |
| 04/04/2002 | US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent |
| 04/04/2002 | US20020040010 Use of agents to treat heart disorders |
| 04/04/2002 | US20020040009 Novel ratA |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039791 Methods and compositions for inhibiting thrombin generation at the surface of cells |
| 04/04/2002 | US20020039789 Method for production of neuroblasts |
| 04/04/2002 | US20020039765 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 04/04/2002 | US20020039764 Nucleic, acids, proteins, and antibodies |
| 04/04/2002 | US20020039759 Polypeptide for use in the prevention of bacterial infection |
| 04/04/2002 | US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam |
| 04/04/2002 | US20020039735 Monoclonal antibodies to ING1 isoforms |
| 04/04/2002 | US20020039734 Detecting preferential lymphocytes in sample; obtain lymphocyte, compare concentration of markers with wild type, adjustment in concentration of markers indicates presence of helper lymphocytes |
| 04/04/2002 | US20020039583 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/04/2002 | US20020039575 Supplying polypepties |
| 04/04/2002 | US20020039574 Delivery of therapeutic gene products by intestinal cell expression |
| 04/04/2002 | US20020039572 Infant gene therapy |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | CA2424062A1 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423588A1 Improved vaccines for proliferative ileitis and methods of making and using the same |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/03/2002 | EP1193272A1 Single-chain insulin analogs |
| 04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
| 04/03/2002 | EP1192278A1 48 human secreted proteins |
| 04/03/2002 | EP1192275A2 Prediction of risk of interstitial lung disease |
| 04/03/2002 | EP1192271A1 Antisense modulation of interleukin-5 signal transduction |
| 04/03/2002 | EP1192268A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192265A1 Anti-viral vectors |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |